According to FutureWise analysis, the market for contrast-enhanced ultrasound in 2023 is US$2.04 billion, and is expected to reach US$2.84 billion by 2031 at a CAGR of 4.2%.

In 2024, the global market for contrast-enhanced ultrasound was valued at approximately USD 2.04 billion, and it is anticipated to grow significantly, reaching around USD 2.99 billion by 2030. This expansion is expected to achieve a robust compound annual growth rate (CAGR) of approximately 5.7% from 2025 to 2030. Several key factors are driving this consistent growth, including an increasing demand for non-invasive and radiation-free diagnostic imaging methods, the broader adoption of affordable microbubble contrast agents, and a rising number of ultrasound procedures performed worldwide. Additionally, the integration of advanced contrast modes into modern ultrasound platforms is enhancing the technology's capabilities and appeal. North America stands out as the leading regional market, bolstered by a well-developed healthcare infrastructure and the early adoption of innovative medical technologies. Meanwhile, Europe and the Asia-Pacific region present expanding growth opportunities, fueled by a rising prevalence of chronic diseases and an increase in diagnostic awareness among healthcare providers and patients alike. This convergence of factors is set to redefine the landscape of diagnostic imaging, further elevating the role of contrast-enhanced ultrasound in clinical practice.

FutureWise Market Research has released a report that provides an intricate analysis of Contrast Enhanced Ultrasound Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=9499&type=requestsample

Contrast Enhanced Ultrasound Market Segmentation:

By Product

• Equipment
• Contrast Agent

By Type

• Non-targeted
• Targeted

By End User

• Hospitals
• Clinics
• Ambulatory Diagnostic Centers

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Contrast-Enhanced Ultrasound Market:

• Lantheus Medical Imaging Inc.
• Bracco Diagnostic Inc.
• General Electric
• Siemens Healthcare GmbH
• nanoPET Pharma GmbH
• ESAOTE SPA
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• BK Medical Holding Company Inc.
• Daiichi Sankyo Company Limited
• GE Healthcare
• Koninklijke Philips NV
• Trivitron Healthcare
• Bristol-Myers Squibb Company
• Acusphere, Inc

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9499&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Contrast Enhanced Ultrasound Market By Product, By Type, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are complimentary with the purchase of any report license.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com